VIVO
Meridian Bioscience Inc
Price:  
33.97 
USD
Volume:  
2,039,919.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VIVO WACC - Weighted Average Cost of Capital

The WACC of Meridian Bioscience Inc (VIVO) is 8.0%.

The Cost of Equity of Meridian Bioscience Inc (VIVO) is 8.05%.
The Cost of Debt of Meridian Bioscience Inc (VIVO) is 4.45%.

Range Selected
Cost of equity 6.90% - 9.20% 8.05%
Tax rate 22.00% - 22.40% 22.20%
Cost of debt 4.00% - 4.90% 4.45%
WACC 6.8% - 9.1% 8.0%
WACC

VIVO WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.59 0.71
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.90% 9.20%
Tax rate 22.00% 22.40%
Debt/Equity ratio 0.02 0.02
Cost of debt 4.00% 4.90%
After-tax WACC 6.8% 9.1%
Selected WACC 8.0%